SYED-MOHAMMED JAFRI: Open Payments
NPI 1801027644 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80,302 in 73 payments from 9 companies in 2025. Trend: 2023 $91,894 · 2024 $47,910 · 2025 $80,302
Consulting: $37,247Speaker / faculty: $34,180Travel & lodging: $5,467Speaker / faculty: $2,170Food & beverage: $1,237
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $34,303 |
| Gilead Sciences, Inc. | 25 | $20,172 |
| VectivBio AG | 4 | $12,457 |
| ABBVIE INC. | 13 | $11,052 |
| Intercept Pharmaceuticals, Inc. | 1 | $2,170 |
| Madrigal Pharmaceuticals | 1 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Dendreon Pharmaceuticals LLC | 1 | $29 |
| Novo Nordisk Inc | 1 | $17 |
Products named: GATTEX, Epclusa, MAVYRET, Livdelzi, OCALIVA, REZDIFFRA, PROVENGE.
Industry payments across MI — which companies pay providers there.
